Abstract:N-nitrosamines (NAs) are potentially highly carcinogenic compounds that have recently been detected in traces in various drug products (DPs). Due to the different physicochemical properties of NAs and active pharmaceutical ingredients (APIs), there is a lack of appropriate analytical methods for simultaneously determining multiple NAs in various DPs. To overcome these limitations, a versatile and innovative analytical approach was developed using a unique sample clean-up procedure by solid phase extraction based on hydrophilic interaction chromatography, which retains high amounts of APIs and polar excipients while allowing NAs of interest to pass through. The samples were analyzed by liquid chromatography coupled with electrospray ionization high-resolution mass spectrometry. The proposed highly sensitive, selective, and robust method was successfully validated, resulting in excellent linearity (R2 > 0.999), accuracy (85-115 %), and precision (RSD <10 %) with adequate recoveries (>80 %), achieving limits of quantitation of at least 42.5 % of regulatory limits. Furthermore, robustness was confirmed for ten DPs (recoveries >80 % and RSD <15 % for all NAs), including those containing up to three APIs. The analytical approach was utilized to examine 26 commercially available and expired DPs. Three NAs (N-nitrosodimethylamine (NDMA), N-nitrosodiethylamine, and N-nitroso-di-n-butylamine) were detected, only NDMA exceeded the limits in expired DPs by up to 32-fold. It was found that special care should be taken when handling samples as NDMA content can be decreased by almost 50 % if samples are not prepared immediately. The approach was tested on 59 different APIs and was confirmed as reliable tool for routine monitoring of 15 NAs in various DPs. Due to its flexibility, the method can be further adapted to the specific API of interest or extended to the newly emerging NA drug substance-related impurities to ensure the safety of DPs and thereby mitigate potential health risks.

Development Of A Reliable Method For N-Nitrosamines In Medicines Determination By Disposable Pipette Extraction And Lc-Ms Analysis

A comprehensive approach for N-nitrosamine determination in pharmaceuticals using a novel HILIC-based solid phase extraction and LC-HRMS

A Practical HPLC-MS Method for the Analysis of Nitrosamine Drug Substance Related Impurities Using an Inexpensive Single Quadrupole Mass Spectrometer

An Agile and Accurate Approach for N-Nitrosamines Detection and Quantification in Medicines by DART-MS

A Novel Molecularly Imprinted Polymer-Solid Phase Extraction Method Coupled with High Performance Liquid Chromatography Tandem Mass Spectrometry for the Determination of Nitrosamines in Water and Beverage Samples.

Determination of 14 nitrosamines at nanogram per liter levels in drinking water.

A New Method Using Liquid Chromatography Tandem Mass Spectrometry to Detect NDMA in Water

Simultaneous determination of low molecular weight nitrosamines in pharmaceutical products by fast gas chromatography mass spectrometry.

Highly Sensitive and Robust LC-MS/MS Method for Determination up to 15 Small Molecule Nitrosamine Impurities in Pharmaceutical Drug Substances

Development and Validation of an HPLC-FLD Method for the Determination of NDMA and NDEA Nitrosamines in Lisinopril Using Pre-Column Denitrosation and Derivatization Procedure

Rapid Analysis of N-Nitrosamines in Urine using Ultra High-Pressure Liquid Chromatography-Mass Spectrometry

Development of a sensitive LC-MS/MS method for simultaneous determination of three nitrosamines in losartan API and assessment of nitrosamines formation

Simple and Practical Method for the Quantitative High-Sensitivity Analysis of N -Nitroso Duloxetine in Duloxetine Drug Products Utilizing LC-MS/MS

Determination of N-Nitrosamines by Gas Chromatography Coupled to Quadrupole–Time-of-Flight Mass Spectrometry in Water Samples

A Rapid Method With Ultra-High-Performance Liquid Chromatography-Tandem Mass Spectrometry For Simultaneous Determination Of Five Type B Trichothecenes In Traditional Chinese Medicines

High resolution GC–Orbitrap MS for nitrosamines analysis: Method performance, exploration of solid phase extraction regularity, and screening of children’s products

Evaluation of a Novel LC-MS/MS Based Analytical Method for the Risk Assessment of Nitrosamines in Pharmaceutical Products and Packaging Materials

Development of a sensitive LC-MS/MS method for determination of N-nitrosopiperazine in levocetirizine

Novel method for monitoring of carcinogenic impurity of N-nitrosamine in nizatidine pharmaceutical products using ultra high-pressure liquid chromatography triple quadrupole mass spectrometry

Simultaneous analysis of carcinogenic N-nitrosamine impurities in metformin tablets using on-line in-tube solid-phase microextraction coupled with liquid chromatography-tandem mass spectrometry

Real-time monitoring of aqueous total N-nitrosamines by UV photolysis and chemiluminescence